Skip to content

The Influence of the Femoral Nerve Block on Quadriceps Strength

The Influence of the Femoral Nerve Block on the Quadriceps Strength After Total Knee Replacement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01111513
Enrollment
135
Registered
2010-04-27
Start date
2007-11-30
Completion date
2012-02-29
Last updated
2012-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty

Keywords

knee surgery, total knee arthroplasty, total knee replacement, ropivacaine, femoral nerve block

Brief summary

Total knee replacement is a frequent procedure in Québec's hospitals and the muscular strength of the quadriceps is the best indicator of the patient's functional recovery post surgery. Thus, the importance of the patient's recovery leads to the evaluation of the influence of the femoral nerve block on the muscle strength. The purpose of the study is to compare the short term and long term recuperation of the quadriceps' motor strength of after a total knee arthroplasty using different types of analgesics such as the continuous femoral nerve block, the single dose femoral nerve block and the systemic analgesic, a patient controlled analgesic pump.

Interventions

DRUG48-hour ropivacaine infusions

Patients receive 20 ml of ropivacaine 0.5 % pre-operation through femoral block catheter, followed by ropivacaine infusions from 0.1 % to 0.1 ml/kg/hour for 48 hours.

Patients receive 20 ml of ropivacaine 0.5% pre-operation

DRUGPatient controlled analgesics

Patient controlled analgesics alone, no femoral block

Sponsors

Sanofi
CollaboratorINDUSTRY
Hopital de l'Enfant-Jesus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 years old * men or women needing an elective total knee replacement surgery

Exclusion criteria

* unicompartmental arthroplasty * revision surgery for knee arthroplasty * previous surgery on same knee * previous fracture of femur/patella with functional after-effects * allergies or contraindication to any medication used during study or to local anaesthesia technique * preexisting neurological deficit * severe anomaly of intracardiac conduction * previous vascular surgery near the site of introduction of the catheter * pregnancy or breastfeeding * ASA IV or V14 class * Men or women \> 18 years old unfit to consent * \< 18 years old * Refusal to sign consent form

Design outcomes

Primary

MeasureTime frameDescription
Quadriceps strength measurement with Cybex machine6 weeks after surgeryEvidence of the influence of the different types of analgesics on the strength of the quadriceps post surgery. Quadriceps strength will be evaluated in open chain and closed chain with the help of the Cybex machine.
Quadriceps strength measurements with Cybex machine12 months after surgeryEvidence of the influence of the different types of analgesics on the strength of the quadriceps post surgery. Quadriceps strength will be evaluated in open chain and closed chain with the help of the Cybex machine.

Secondary

MeasureTime frameDescription
Overall functional recovery6 weeks after surgeryThe overall functional recovery of the patient will be evaluated considering the analgesic type using SF-36 and WOMAC questionnaires.
Pain score on Visual Analog Scale (VAS)every 6 hour for the 48 hours following surgeryEvaluation of the effectiveness of the analgesics on pain with VAS .
Hospital stay length4 to 7 days after surgeryEvaluation of the hospital stay length after total knee replacement taking into account the different types of analgesics.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026